These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

661 related items for PubMed ID: 26275994

  • 1. Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis.
    Yang R, Qu C, Zhou Y, Konkel JE, Shi S, Liu Y, Chen C, Liu S, Liu D, Chen Y, Zandi E, Chen W, Zhou Y, Shi S.
    Immunity; 2015 Aug 18; 43(2):251-63. PubMed ID: 26275994
    [Abstract] [Full Text] [Related]

  • 2. Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression.
    Nakatsukasa H, Oda M, Yin J, Chikuma S, Ito M, Koga-Iizuka M, Someya K, Kitagawa Y, Ohkura N, Sakaguchi S, Koya I, Sanosaka T, Kohyama J, Tsukada YI, Yamanaka S, Takamura-Enya T, Lu Q, Yoshimura A.
    Int Immunol; 2019 Apr 26; 31(5):335-347. PubMed ID: 30726915
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of Tet2 is associated with Foxp3 TSDR hypermethylation in regulatory T cell of allergic rhinitis.
    Tan L, Qiu T, Xiang R, Cao C, Deng Y, Tao Z, Xu Y.
    Life Sci; 2020 Jan 15; 241():117101. PubMed ID: 31778687
    [Abstract] [Full Text] [Related]

  • 4. TETs Link Hydrogen Sulfide to Immune Tolerance.
    Oh SA, Li MO.
    Immunity; 2015 Aug 18; 43(2):211-3. PubMed ID: 26287675
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Loss of TET2 and TET3 in regulatory T cells unleashes effector function.
    Yue X, Lio CJ, Samaniego-Castruita D, Li X, Rao A.
    Nat Commun; 2019 May 01; 10(1):2011. PubMed ID: 31043609
    [Abstract] [Full Text] [Related]

  • 7. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ, Lodh A, Choi JH, van Riggelen J.
    Epigenetics Chromatin; 2019 Jul 02; 12(1):41. PubMed ID: 31266538
    [Abstract] [Full Text] [Related]

  • 8. STAT5 and TET2 Cooperate to Regulate FOXP3-TSDR Demethylation in CD4+ T Cells of Patients with Colorectal Cancer.
    Ma H, Gao W, Sun X, Wang W.
    J Immunol Res; 2018 Jul 02; 2018():6985031. PubMed ID: 30013992
    [Abstract] [Full Text] [Related]

  • 9. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.
    Chen Q, Kim YC, Laurence A, Punkosdy GA, Shevach EM.
    J Immunol; 2011 Jun 01; 186(11):6329-37. PubMed ID: 21525380
    [Abstract] [Full Text] [Related]

  • 10. Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation.
    Someya K, Nakatsukasa H, Ito M, Kondo T, Tateda KI, Akanuma T, Koya I, Sanosaka T, Kohyama J, Tsukada YI, Takamura-Enya T, Yoshimura A.
    Int Immunol; 2017 Aug 01; 29(8):365-375. PubMed ID: 29048538
    [Abstract] [Full Text] [Related]

  • 11. Mbd2 promotes foxp3 demethylation and T-regulatory-cell function.
    Wang L, Liu Y, Han R, Beier UH, Thomas RM, Wells AD, Hancock WW.
    Mol Cell Biol; 2013 Oct 01; 33(20):4106-15. PubMed ID: 23979593
    [Abstract] [Full Text] [Related]

  • 12. CRISPR/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells.
    Wilk C, Effenberg L, Abberger H, Steenpass L, Hansen W, Zeschnigk M, Kirschning C, Buer J, Kehrmann J.
    Cell Immunol; 2022 Jan 01; 371():104471. PubMed ID: 34954490
    [Abstract] [Full Text] [Related]

  • 13. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation.
    Sohni A, Bartoccetti M, Khoueiry R, Spans L, Vande Velde J, De Troyer L, Pulakanti K, Claessens F, Rao S, Koh KP.
    Mol Cell Biol; 2015 Mar 01; 35(6):1026-42. PubMed ID: 25582196
    [Abstract] [Full Text] [Related]

  • 14. Membrane-bound Dickkopf-1 in Foxp3+ regulatory T cells suppresses T-cell-mediated autoimmune colitis.
    Chae WJ, Park JH, Henegariu O, Yilmaz S, Hao L, Bothwell ALM.
    Immunology; 2017 Oct 01; 152(2):265-275. PubMed ID: 28556921
    [Abstract] [Full Text] [Related]

  • 15. Control of Foxp3 stability through modulation of TET activity.
    Yue X, Trifari S, Äijö T, Tsagaratou A, Pastor WA, Zepeda-Martínez JA, Lio CW, Li X, Huang Y, Vijayanand P, Lähdesmäki H, Rao A.
    J Exp Med; 2016 Mar 07; 213(3):377-97. PubMed ID: 26903244
    [Abstract] [Full Text] [Related]

  • 16. Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.
    Qi Q, Wang Q, Liu K, Bian J, Yu Z, Hou J.
    Int J Mol Sci; 2022 Jul 31; 23(15):. PubMed ID: 35955629
    [Abstract] [Full Text] [Related]

  • 17. DNA methylation controls Foxp3 gene expression.
    Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, Baron U, Olek S, Hamann A, von Boehmer H, Huehn J.
    Eur J Immunol; 2008 Jun 31; 38(6):1654-63. PubMed ID: 18493985
    [Abstract] [Full Text] [Related]

  • 18. Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells.
    Vincent JJ, Huang Y, Chen PY, Feng S, Calvopiña JH, Nee K, Lee SA, Le T, Yoon AJ, Faull K, Fan G, Rao A, Jacobsen SE, Pellegrini M, Clark AT.
    Cell Stem Cell; 2013 Apr 04; 12(4):470-8. PubMed ID: 23415914
    [Abstract] [Full Text] [Related]

  • 19. Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter.
    Yang R, Yu T, Kou X, Gao X, Chen C, Liu D, Zhou Y, Shi S.
    Nat Commun; 2018 Jun 01; 9(1):2143. PubMed ID: 29858571
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.